BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33021406)

  • 1. Biomedical application of chondroitin sulfate with nanoparticles in drug delivery systems: systematic review.
    Amhare AF; Lei J; Deng H; Lv Y; Han J; Zhang L
    J Drug Target; 2021 Mar; 29(3):259-268. PubMed ID: 33021406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembled nanoparticles based on chondroitin sulfate-deoxycholic acid conjugates for docetaxel delivery: Effect of degree of substitution of deoxycholic acid.
    Liu M; Du H; Zhai G
    Colloids Surf B Biointerfaces; 2016 Oct; 146():235-44. PubMed ID: 27343846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroitin sulfate-based nanocarriers for drug/gene delivery.
    Zhao L; Liu M; Wang J; Zhai G
    Carbohydr Polym; 2015 Nov; 133():391-9. PubMed ID: 26344295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chondroitin sulfate derived theranostic nanoparticles for targeted drug delivery.
    Varghese OP; Liu J; Sundaram K; Hilborn J; Oommen OP
    Biomater Sci; 2016 Aug; 4(9):1310-3. PubMed ID: 27431007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
    Lee JY; Chung SJ; Cho HJ; Kim DD
    Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro evaluation of novel cross-linked chondroitin sulphate nanoparticles by aluminium ions for encapsulation of green tea flavonoids.
    Varshosaz J; Asefi H; Hashemi-Beni B; Ghaffari S; Davoudi A
    IET Nanobiotechnol; 2018 Sep; 12(6):757-763. PubMed ID: 30104449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembled nanoparticles of reduction-sensitive poly (lactic-co-glycolic acid)-conjugated chondroitin sulfate A for doxorubicin delivery: preparation, characterization and evaluation.
    Wang XF; Ren J; He HQ; Liang L; Xie X; Li ZX; Zhao JG; Yu JM
    Pharm Dev Technol; 2019 Jul; 24(6):794-802. PubMed ID: 30907676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the lecithin addition in the properties and cytotoxic activity of chitosan and chondroitin sulfate nanoparticles containing curcumin.
    Jardim KV; Siqueira JLN; Báo SN; Sousa MH; Parize AL
    Carbohydr Polym; 2020 Jan; 227():115351. PubMed ID: 31590861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme/pH-triggered anticancer drug delivery of chondroitin sulfate modified doxorubicin nanocrystal.
    Liang Y; Fu X; Du C; Xia H; Lai Y; Sun Y
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):1114-1124. PubMed ID: 32880192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox/enzyme sensitive chondroitin sulfate-based self-assembled nanoparticles loading docetaxel for the inhibition of metastasis and growth of melanoma.
    Liu M; Du H; Khan AR; Ji J; Yu A; Zhai G
    Carbohydr Polym; 2018 Mar; 184():82-93. PubMed ID: 29352946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient weapon for protracted warfare to malaria: A chondroitin sulfate derivates-containing injectable, ultra-long-lasting meshy-gel system.
    Luo J; Zhang P; Liu R; Li X; Hua P; Li S; Zhang T; Zhang T; Fu Y; Song X; Gong T; Zhang Z
    Carbohydr Polym; 2019 Jun; 214():131-141. PubMed ID: 30925981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyethylene glycol-conjugated chondroitin sulfate A derivative nanoparticles for tumor-targeted delivery of anticancer drugs.
    Lee JY; Park JH; Lee JJ; Lee SY; Chung SJ; Cho HJ; Kim DD
    Carbohydr Polym; 2016 Oct; 151():68-77. PubMed ID: 27474544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile preparation of pH-sensitive micelles self-assembled from amphiphilic chondroitin sulfate-histamine conjugate for triggered intracellular drug release.
    Yu C; Gao C; Lü S; Chen C; Yang J; Di X; Liu M
    Colloids Surf B Biointerfaces; 2014 Mar; 115():331-9. PubMed ID: 24398081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel.
    Lee HS; Kang NW; Kim H; Kim DH; Chae JW; Lee W; Song GY; Cho CW; Kim DD; Lee JY
    Carbohydr Polym; 2021 Feb; 253():117187. PubMed ID: 33278965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
    Li Y; Chen X; Ji J; Li L; Zhai G
    Carbohydr Polym; 2021 Mar; 255():117393. PubMed ID: 33436222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondroitin sulfate derived theranostic and therapeutic nanocarriers for tumor-targeted drug delivery.
    Khan AR; Yang X; Du X; Yang H; Liu Y; Khan AQ; Zhai G
    Carbohydr Polym; 2020 Apr; 233():115837. PubMed ID: 32059890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroitin sulfate-capped super-paramagnetic iron oxide nanoparticles as potential carriers of doxorubicin hydrochloride.
    Mallick N; Anwar M; Asfer M; Mehdi SH; Rizvi MMA; Panda AK; Talegaonkar S; Ahmad FJ
    Carbohydr Polym; 2016 Oct; 151():546-556. PubMed ID: 27474599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CD44-Targeting Programmable Drug Delivery System for Enhancing and Sensitizing Chemotherapy to Drug-Resistant Cancer.
    Zhang M; Ma Y; Wang Z; Han Z; Gao W; Zhou Q; Gu Y
    ACS Appl Mater Interfaces; 2019 Feb; 11(6):5851-5861. PubMed ID: 30648841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization.
    Yadav AK; Agarwal A; Jain S; Mishra AK; Bid H; Rai G; Agrawal H; Agrawal GP
    J Biomed Nanotechnol; 2010 Aug; 6(4):340-50. PubMed ID: 21323107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of rosuvastatin-loaded chitosan/chondroitin sulfate nanoparticles into a thermosensitive hydrogel for bone tissue engineering: preparation, characterization, and cellular behavior.
    Rezazadeh M; Parandeh M; Akbari V; Ebrahimi Z; Taheri A
    Pharm Dev Technol; 2019 Mar; 24(3):357-367. PubMed ID: 29863957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.